Archer Investment Corp Charles River Laboratories International, Inc. Transaction History

Archer Investment Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $65,666 - $93,062	-257 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $8,825 - $11,149	30 Added 13.22%	257 $95.1 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $18,225 - $21,862	73 Added 47.4%	227 $65.8 Million
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $34,188 - $38,903	154 New	154 $38.5 Million

693

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Archer Investment Corp with notifications on news.